An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Silvia Marsoni Nicoletta Colombo Giovanni Scambia Angiolo Gadducci Francesco Bertoni |
| Publication date | June 1, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |